AAM
WST icon

Ardevora Asset Management’s West Pharmaceutical WST Stock Holding History

Ardevora Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$5.62M Sell
15,945
-11,511
-42% -$4.07M 0.5% 86
2023
Q3 		$10.3M Sell
27,456
-68,944
-72% -$26.7M 0.51% 79
2023
Q2 		$36.9M Buy
+96,400
New +$34.4M 0.89% 42

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ardevora Asset Management's WST Position: Q4 2023 in Review

Ardevora Asset Management reduced its West Pharmaceutical (WST) stake by 42% in Q4 2023, selling an estimated $4.07M and leaving 15,945 shares worth $5.62M. The position accounts for 0.5% of the portfolio, ranked #86.

Ardevora Asset Management first reported a position in WST in Q2 2023 and has held it in 3 quarters since. The position peaked at $36.9M in Q2 2023. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Ardevora Asset Management held 15,945 shares of West Pharmaceutical worth $5.62M as of Q4 2023.
  • Ardevora Asset Management sold 11,511 West Pharmaceutical shares in Q4 2023, an estimated $4.07M.
  • West Pharmaceutical made up 0.5% of Ardevora Asset Management's portfolio in Q4 2023, its #86 holding.
  • Ardevora Asset Management first reported a position in West Pharmaceutical in Q2 2023 and has held it in 3 quarters since.
  • Ardevora Asset Management's West Pharmaceutical position peaked at $36.9M in Q2 2023.
  • 782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.